These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 36052721)

  • 1. Age-specific associations between underlying health conditions and hospitalisation, death and in-hospital death among confirmed COVID-19 cases: a multi-country study based on surveillance data, June to December 2020.
    Funk T; Innocenti F; Gomes Dias J; Nerlander L; Melillo T; Gauci C; Melillo JM; Lenz P; Sebestova H; Slezak P; Vlckova I; Berild JD; Mauroy C; Seppälä E; Tønnessen R; Vergison A; Mossong J; Masi S; Huiart L; Cullen G; Murphy N; O'Connor L; O'Donnell J; Mook P; Pebody RG; Bundle N
    Euro Surveill; 2022 Sep; 27(35):. PubMed ID: 36052721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid Epidemiological Analysis of Comorbidities and Treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): A population-based case-control study.
    McKeigue PM; Weir A; Bishop J; McGurnaghan SJ; Kennedy S; McAllister D; Robertson C; Wood R; Lone N; Murray J; Caparrotta TM; Smith-Palmer A; Goldberg D; McMenamin J; Ramsay C; Hutchinson S; Colhoun HM;
    PLoS Med; 2020 Oct; 17(10):e1003374. PubMed ID: 33079969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimising health and economic impacts of COVID-19 vaccine prioritisation strategies in the WHO European Region.
    Liu Y; Sandmann FG; Barnard RC; Pearson CAB; ; Pastore R; Pebody R; Flasche S; Jit M
    medRxiv; 2021 Jul; ():. PubMed ID: 34282421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospitalisation and mortality from COVID-19 in Mexican indigenous people: a cross-sectional observational study.
    Serván-Mori E; Seiglie JA; Gómez-Dantés O; Wirtz VJ
    J Epidemiol Community Health; 2022 Jan; 76(1):16-23. PubMed ID: 34266980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, demographical characteristics and hospitalisation of 3,010 patients with Covid-19 in Friuli Venezia Giulia Region (Northern Italy). A multivariate, population-based, statistical analysis.
    Gobbato M; Clagnan E; Burba I; Rizzi L; Grassetti L; Del Zotto S; Dal Maso L; Serraino D; Tonutti G
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):226-234. PubMed ID: 33412814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants for hospitalisations, intensive care unit admission and death among 20,293 reported COVID-19 cases in Portugal, March to April 2020.
    Ricoca Peixoto V; Vieira A; Aguiar P; Sousa P; Carvalho C; Thomas D; Abrantes A; Nunes C
    Euro Surveill; 2021 Aug; 26(33):. PubMed ID: 34414882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration of vaccine effectiveness against SARS-CoV-2 infection, hospitalisation, and death in residents and staff of long-term care facilities in England (VIVALDI): a prospective cohort study.
    Shrotri M; Krutikov M; Nacer-Laidi H; Azmi B; Palmer T; Giddings R; Fuller C; Irwin-Singer A; Baynton V; Tut G; Moss P; Hayward A; Copas A; Shallcross L
    Lancet Healthy Longev; 2022 Jul; 3(7):e470-e480. PubMed ID: 35813279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: a population-based cohort study.
    Piernas C; Patone M; Astbury NM; Gao M; Sheikh A; Khunti K; Shankar-Hari M; Dixon S; Coupland C; Aveyard P; Hippisley-Cox J; Jebb SA
    Lancet Diabetes Endocrinol; 2022 Aug; 10(8):571-580. PubMed ID: 35780805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study.
    Jassat W; Cohen C; Tempia S; Masha M; Goldstein S; Kufa T; Murangandi P; Savulescu D; Walaza S; Bam JL; Davies MA; Prozesky HW; Naude J; Mnguni AT; Lawrence CA; Mathema HT; Zamparini J; Black J; Mehta R; Parker A; Chikobvu P; Dawood H; Muvhango N; Strydom R; Adelekan T; Mdlovu B; Moodley N; Namavhandu EL; Rheeder P; Venturas J; Magula N; Blumberg L;
    Lancet HIV; 2021 Sep; 8(9):e554-e567. PubMed ID: 34363789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing real-world vaccine effectiveness against severe forms of SARS-CoV-2 infection: an observational study from routine surveillance data in Switzerland.
    Anderegg N; Althaus CL; Colin S; Hauser A; Laube A; Mäusezahl M; Wagner M; Zaffora B; Riou J
    Swiss Med Wkly; 2022 Apr; 152():w30163. PubMed ID: 35752951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demographics, clinical characteristics, and outcomes of 27,256 hospitalized COVID-19 patients in Kermanshah Province, Iran: a retrospective one-year cohort study.
    Hesni E; Sayad B; Khosravi Shadmani F; Najafi F; Khodarahmi R; Rahimi Z; Bozorgomid A; Sayad N
    BMC Infect Dis; 2022 Mar; 22(1):319. PubMed ID: 35361161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.
    Antonelli M; Penfold RS; Merino J; Sudre CH; Molteni E; Berry S; Canas LS; Graham MS; Klaser K; Modat M; Murray B; Kerfoot E; Chen L; Deng J; Österdahl MF; Cheetham NJ; Drew DA; Nguyen LH; Pujol JC; Hu C; Selvachandran S; Polidori L; May A; Wolf J; Chan AT; Hammers A; Duncan EL; Spector TD; Ourselin S; Steves CJ
    Lancet Infect Dis; 2022 Jan; 22(1):43-55. PubMed ID: 34480857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which children and young people are at higher risk of severe disease and death after hospitalisation with SARS-CoV-2 infection in children and young people: A systematic review and individual patient meta-analysis.
    Harwood R; Yan H; Talawila Da Camara N; Smith C; Ward J; Tudur-Smith C; Linney M; Clark M; Whittaker E; Saatci D; Davis PJ; Luyt K; Draper ES; Kenny SE; Fraser LK; Viner RM
    EClinicalMedicine; 2022 Feb; 44():101287. PubMed ID: 35169689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.
    Tenforde MW; Self WH; Adams K; Gaglani M; Ginde AA; McNeal T; Ghamande S; Douin DJ; Talbot HK; Casey JD; Mohr NM; Zepeski A; Shapiro NI; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Exline MC; Gong MN; Mohamed A; Henning DJ; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; Gordon AJ; Qadir N; Chang SY; Mallow C; Rivas C; Babcock HM; Kwon JH; Halasa N; Chappell JD; Lauring AS; Grijalva CG; Rice TW; Jones ID; Stubblefield WB; Baughman A; Womack KN; Rhoads JP; Lindsell CJ; Hart KW; Zhu Y; Olson SM; Kobayashi M; Verani JR; Patel MM;
    JAMA; 2021 Nov; 326(20):2043-2054. PubMed ID: 34734975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of hospitalisation and death due to SARS-CoV-2 infection in Finland: A population-based register study with implications to vaccinations.
    Salo H; Lehtonen T; Auranen K; Baum U; Leino T
    Vaccine; 2022 May; 40(24):3345-3355. PubMed ID: 35489984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of cardiometabolic risk factors with hospitalisation or death due to COVID-19: population-based cohort study in Sweden (SCAPIS).
    Tornhammar P; Jernberg T; Bergström G; Blomberg A; Engström G; Engvall J; Fall T; Gisslén M; Janson C; Lind L; Sköld CM; Sundström J; Söderberg S; Zaigham S; Östgren CJ; Andersson DP; Ueda P
    BMJ Open; 2021 Sep; 11(9):e051359. PubMed ID: 34475186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study.
    Gram MA; Nielsen J; Schelde AB; Nielsen KF; Moustsen-Helms IR; Sørensen AKB; Valentiner-Branth P; Emborg HD
    PLoS Med; 2021 Dec; 18(12):e1003874. PubMed ID: 34919548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative vaccine effectiveness against severe COVID-19 over time in US hospital administrative data: a case-control study.
    Wright BJ; Tideman S; Diaz GA; French T; Parsons GT; Robicsek A
    Lancet Respir Med; 2022 Jun; 10(6):557-565. PubMed ID: 35227415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
    Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
    Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.
    Ng OT; Marimuthu K; Lim N; Lim ZQ; Thevasagayam NM; Koh V; Chiew CJ; Ma S; Koh M; Low PY; Tan SB; Ho J; Maurer-Stroh S; Lee VJM; Leo YS; Tan KB; Cook AR; Tan CC
    JAMA Netw Open; 2022 Aug; 5(8):e2228900. PubMed ID: 36018588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.